TSC22D3 and diabetes mellitus: Our previous11 and current findings revealed that detailed molecular mechanisms by glucocorticoids suppressed diabetes (ie inflammation and hypoxia)‐induced galectin‐1 expression via transactivation of DUSP‐1 and TSC22D3, respectively.